ReviewFrontiers in pharmacology2022

The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC.

Ji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.